サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1267434

ゲノミクスの世界市場：製品・サービス別 (消耗品、装置・システム・ソフトウェア)・技術別 (シーケンシング、PCR、マイクロアレイ)・研究の種類別 (エピゲノミクス、バイオマーカー発見)・用途別 (創薬、診断、農業)・地域別の将来予測 (2028年まで)

Genomics Market by Product & Service (Consumables, Instrument, System & Software), Technology (Sequencing, PCR, Microarray), Study Type (Epigenomics, Biomarker Discovery), Application (Drug Discovery, Diagnostic, Agriculture) - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 395 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.46円
ゲノミクスの世界市場：製品・サービス別 (消耗品、装置・システム・ソフトウェア)・技術別 (シーケンシング、PCR、マイクロアレイ)・研究の種類別 (エピゲノミクス、バイオマーカー発見)・用途別 (創薬、診断、農業)・地域別の将来予測 (2028年まで)
出版日: 2023年04月27日
発行: MarketsandMarkets
ページ情報: 英文 395 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のゲノミクスの市場規模は、2023年の462億米ドルから、2028年には831億米ドルに達し、予測期間中 (2023年～2028年) に12.4%のCAGRで成長すると予測されます。

シーケンシング技術の継続的な発展や、ゲノミクスに対するより深い理解により、疾患検出におけるバイオマーカーの効率は向上しています。正確な診断と個別化医療で生存率を高め、国民健康保険制度の財政負担を軽減できるため、世界中の政府がゲノム科学に多額の投資を行っており、ゲノミクス市場の主要企業は相互に、また中小企業やバイオ医薬品企業などのエンドユーザーとの協力関係を深め、世界中で製品の提供を拡大しており、それが市場成長を促進しています。しかし、熟練した研究者の不足、倫理的な問題、大量のゲノミクスデータの安全な保存に関連する問題などが、市場成長の妨げとなっています。

消耗品・試薬は、製品・サービス別で最大のシェアを占める

製品・サービス別に見ると、2022年には消耗品・試薬のセグメントがゲノミクス市場で最大のシェアを占めています。診断・個別化医療・創薬・動物研究など、さまざまな分野でゲノミクスの活用が進んでいることが、予測期間中に消耗品・試薬の市場を押し上げると予想されます。

マイクロアレイのセグメントは、ゲノミクス市場の技術セグメント別で、最も低い市場成長率となる

ゲノミクス市場では、2022年にマイクロアレイ技術が最も低い市場成長率となっています。マイクロアレイ技術は、遺伝子発見、疾病診断、創薬、がん研究、毒物学研究などに応用されています。しかし、シーケンシング技術の採用が進んでいるため、この市場の成長はある程度制限されるでしょう。

欧州はゲノミクス市場において2番目に大きな地域である

欧州は北米に次いで、ゲノミクス開発が集中的に行われ、NGSベースの診断検査が上市され、またゲノミクス製品の使用に関する企業や研究機関の間の協力が進んでいます。そうした要因が、同地域の市場成長を促進すると予測されます。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 機会
    • 課題
    • 動向
  • 技術分析
  • バリューチェーン分析
  • 規制分析
  • ゲノミクス市場のエコシステムの分析
  • 顧客ビジネスに影響を与える動向/混乱
  • 価格分析
  • 主な会議とイベント (2023年～2024年)
  • ポーターのファイブフォース分析
  • 特許分析
  • 主な利害関係者と購入基準

第6章 ゲノミクス市場：製品・サービス別

  • イントロダクション
  • 消耗品・試薬
  • サービス
  • 装置・システム・ソフトウェア

第7章 ゲノミクス市場：技術別

  • イントロダクション
  • シーケンシング
  • PCR
  • フローサイトメトリー
  • マイクロアレイ
  • その他の技術

第8章 ゲノミクス市場：用途別

  • イントロダクション
  • 創薬・開発
  • 診断
  • 農業・動物研究
  • その他の用途

第9章 ゲノミクス市場：研究の種類別

  • イントロダクション
  • 機能ゲノミクス
  • バイオマーカー発見
  • パスウェイ解析
  • エピゲノミクス
  • その他の研究の種類

第10章 ゲノミクス市場：エンドユーザー別

  • イントロダクション
  • 病院・診療所
  • 学術・研究機関
  • 製薬・バイオテクノロジー企業
  • その他のエンドユーザー

第11章 ゲノミクス市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第12章 競合情勢

  • イントロダクション
  • 主要企業が採用した戦略
  • 収益分析
  • 市場シェア分析
  • 企業評価マトリックス
  • 競合ベンチマーキング
  • 企業評価マトリックス：スタートアップ/中小企業向け
  • 競合ベンチマーキング：スタートアップ/中小企業向け
  • 競合シナリオと動向

第13章 企業プロファイル

  • 主要企業
    • ILLUMINA, INC.
    • THERMO FISHER SCIENTIFIC INC.
    • F. HOFFMANN-LA ROCHE LTD.
    • DANAHER CORPORATION
    • QIAGEN N.V.
    • AGILENT TECHNOLOGIES, INC.
    • PERKINELMER INC.
    • BIO-RAD LABORATORIES, INC.
    • EUROFINS SCIENTIFIC
    • PACIFIC BIOSCIENCES
    • OXFORD NANOPORE TECHNOLOGIES PLC
    • TAKARA BIO INC.
    • BGI GROUP
    • EPPENDORF AG
    • MERCK KGAA
    • BECTON, DICKINSON AND COMPANY
    • ABBOTT LABORATORIES
    • 23ANDME, INC.
    • 10X GENOMICS
    • NEW ENGLAND BIOLABS
    • PROMEGA CORPORATION
    • CREATIVE BIOGENE
    • NOVOGENE CO., LTD.
    • ULTIMA GENOMICS, INC.
    • FREENOME HOLDINGS, INC.
  • その他の企業
    • QUEST DIAGNOSTICS
    • MYRIAD GENETICS, INC.
    • PERSONALIS, INC.
    • HELIX OPCO, LLC
    • POLARIS GENOMICS
    • PHALANX BIOTECH GROUP
    • GENOMIQA PTY LTD

第14章 付録

目次
Product Code: BT 2209

The global genomics market is projected to reach USD 83.1 billion by 2028 from USD 46.2 billion in 2023, at a CAGR of 12.4% during the forecast period of 2023 to 2028. . Continuous developments in sequencing technologies and a better understanding of genomics have increased the efficiency of biomarkers in disease detection. Since precise diagnosis and personalized medicine increase survival rates as well as reduce the financial burden on national health insurance programs, governments across the globe are making significant investments in genome sciences, and key players in the genomics market are increasingly collaborating with each other as well as with smaller players, biopharmaceutical companies, and other end users to expand their product offerings across the globe which is promoting market growth. However, dearth of skilled players, ethical issues and the issues associated with secure storage of large volume genomics data is hampering market growth.

Consumables & Reagents is expected to account for the largest share for product and services segment.

Based on product and service, the genomics market is segmented into consumables and reagents, services, and instruments, systems, and software. In 2022, the consumables and reagents segment accounted for the largest share of the genomics market. The growing applications of genomics in various fields, such as diagnostics, personalized medicine, and drug discovery, animal research, are expected to boost the market for consumables and reagents during the forecast period.

The microarrays segment accounted for the lowest market growth of the technology segment in the genomics market

On the basis of technology, the genomics market is segmented into sequencing, PCR, microarrays, flow cytometry, and other technologies. In 2022, microarray technology accounted for the lowest market growth. Microarray technology has applications in gene discovery, disease diagnosis, drug discovery, cancer research, and toxicological research. However, the increasing adoption of sequencing technologies will limit the growth of this market to a certain extent.

Europe is the second largest region in the genomics market

The genomics market is segmented into North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA). After North America, In Europe, extensive developments in genomics, the launch of NGS-based diagnostic tests, and collaborations among industry players and research institutes for the use of genomics products are projected to drive market growth in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 80% and Demand Side 20%
  • By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
  • By Region: North America -30%, Europe -20%, Asia-Pacific -35%, Latin America -10%, and Middle East and Africa - 5%

Prominent Players of the genomics market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland).

Research Coverage:

This report provides a detailed picture of the genomics market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, technology, study type, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall genomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing government funding to support genomics projects, Rising incidence and prevalence of viral diseases and genetic disorders, Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research, Robust investments in genomics startups, Growing applications of genomics), opportunities (use of genomics in specialized/personalized medicine), challenges (ethical issues, dearth of trained professionals, secure storage of large volume data), trends (Partnerships and collaborations for technological advancements in genomics, AI in genomics) influencing the growth of genomics market.
  • Product & Service Development/Innovation: Detailed insights on newly launched product and services, and technological assessment of the genomics market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the genomics market across varied regions.
  • Market Diversification: Exhaustive information about new product and services, untapped geographies, recent developments, and investments in the genomics market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), among others in the genomics market. The report also helps stakeholders understand the pulse of genomics market and provides them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 PRIMARY RESEARCH
    • FIGURE 2 GENOMICS MARKET: PRIMARY RESPONDENTS
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 GENOMICS MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION)
    • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 6 GENOMICS MARKET: CAGR PROJECTIONS
    • FIGURE 7 GENOMICS MARKET: GROWTH ANALYSIS OF DEMAND-SIDE FACTORS
  • 2.4 DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
  • 2.6 RISK ANALYSIS
  • 2.7 RECESSION IMPACT
    • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2027 (% GROWTH)
    • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
    • TABLE 3 US HEALTH EXPENDITURE, 2023-2027 (USD MILLION)

3 EXECUTIVE SUMMARY

    • FIGURE 9 GENOMICS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 GENOMICS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 GENOMICS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 GENOMICS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF GENOMICS MARKET

4 PREMIUM INSIGHTS

  • 4.1 GENOMICS MARKET OVERVIEW
    • FIGURE 14 RISING PREVALENCE OF GENETIC DISORDERS TO DRIVE MARKET
  • 4.2 NORTH AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
    • FIGURE 15 CONSUMABLES AND REAGENTS ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.3 GENOMICS MARKET SHARE, BY APPLICATION, 2023 VS. 2028
    • FIGURE 16 DRUG DISCOVERY AND DEVELOPMENT SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2028
  • 4.4 GENOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 GENOMICS MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS
    • TABLE 4 GENOMICS MARKET: IMPACT ANALYSIS OF DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing government funding to support genomics projects
      • 5.2.1.2 Rising incidence and prevalence of viral diseases and genetic disorders
    • FIGURE 19 BURDEN OF HIV INFECTIONS, BY REGION, 2021
      • 5.2.1.3 Growing incidence of cancer and increasing applications of next-generation sequencing in cancer research
    • TABLE 5 CANCER INCIDENCE, 2020 VS. 2040
      • 5.2.1.4 Robust investments in genomics startups
      • 5.2.1.5 Growing applications of genomics
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Use of genomics in specialized/personalized medicine
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Ethical issues
      • 5.2.3.2 Dearth of trained professionals
      • 5.2.3.3 Secure storage of large volumes of sequenced data
    • 5.2.4 TRENDS
      • 5.2.4.1 Partnerships and collaborations for technological advancements in genomics
      • 5.2.4.2 AI in genomics
  • 5.3 TECHNOLOGY ANALYSIS
    • TABLE 6 COMPARISON OF SANGER SEQUENCING AND NGS
    • TABLE 7 COMPARISON OF PCR TECHNOLOGIES
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 20 VALUE CHAIN ANALYSIS-MAXIMUM VALUE ADDED DURING SEQUENCING AND ANALYSIS PHASES
  • 5.5 REGULATORY ANALYSIS
    • 5.5.1 NORTH AMERICA
      • 5.5.1.1 US
    • TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.5.1.2 Canada
    • 5.5.2 EUROPE
    • 5.5.3 ASIA PACIFIC
      • 5.5.3.1 China
    • TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.5.3.2 Japan
      • 5.5.3.3 India
    • 5.5.4 LATIN AMERICA
    • 5.5.5 MIDDLE EAST
  • 5.6 ECOSYSTEM ANALYSIS OF GENOMICS MARKET
    • FIGURE 21 ECOSYSTEM ANALYSIS OF GENOMICS MARKET
  • 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
    • FIGURE 22 REVENUE SHIFT AND NEW REVENUE POCKETS
  • 5.8 PRICING ANALYSIS
    • 5.8.1 AVERAGE SELLING PRICE OF NGS PRODUCTS
    • TABLE 11 AVERAGE SELLING PRICE OF NGS SYSTEMS, BY KEY PLAYER (2022)
    • 5.8.2 AVERAGE SELLING PRICE OF PCR PRODUCTS
    • TABLE 12 AVERAGE SELLING PRICE OF PCR SYSTEMS, BY KEY PLAYER (2022)
    • 5.8.3 AVERAGE SELLING PRICE TREND ANALYSIS
    • FIGURE 23 GENOME SEQUENCING PRICING TREND
  • 5.9 KEY CONFERENCES AND EVENTS IN 2023-2024
    • TABLE 13 GENOMICS MARKET: LIST OF CONFERENCES AND EVENTS
  • 5.10 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 14 GENOMICS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.10.1 THREAT OF NEW ENTRANTS
    • 5.10.2 THREAT OF SUBSTITUTES
    • 5.10.3 BARGAINING POWER OF SUPPLIERS
    • 5.10.4 BARGAINING POWER OF BUYERS
    • 5.10.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.11 PATENT ANALYSIS
    • FIGURE 24 PATENT APPLICATIONS FOR GENOMICS (NEXT-GENERATION SEQUENCING) MARKET, JANUARY 2012-MARCH 2023
    • TABLE 15 INDICATIVE LIST OF PATENTS IN GENOMICS (NEXT-GENERATION SEQUENCING) MARKET
    • FIGURE 25 PATENT APPLICATIONS FOR GENOMICS (POLYMERASE CHAIN REACTION) MARKET, JANUARY 2012-MARCH 2023
    • TABLE 16 INDICATIVE LIST OF PATENTS IN GENOMICS (POLYMERASE CHAIN REACTION) MARKET
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF GENOMICS PRODUCTS AND SERVICES
    • FIGURE 27 BUYING CRITERIA FOR GENOMICS PRODUCTS

6 GENOMICS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 17 GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
  • 6.2 CONSUMABLES AND REAGENTS
    • 6.2.1 GROWING APPLICATIONS OF GENOMICS IN VARIOUS FIELDS TO DRIVE ADOPTION
    • TABLE 18 GENOMICS CONSUMABLES AND REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 19 NORTH AMERICA: GENOMICS CONSUMABLES AND REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 20 EUROPE: GENOMICS CONSUMABLES AND REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 21 ASIA PACIFIC: GENOMICS CONSUMABLES AND REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 SERVICES
    • 6.3.1 LACK OF IN-HOUSE EXPERTISE FOR INTERPRETATION OF GENOMICS DATA TO BOOST MARKET FOR OUTSOURCING SERVICES
    • TABLE 22 GENOMICS SERVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 23 NORTH AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 24 EUROPE: GENOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 25 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.4 INSTRUMENTS, SYSTEMS, AND SOFTWARE
    • 6.4.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH
    • TABLE 26 LIST OF COMPANIES OFFERING MICROARRAY SCANNERS
    • TABLE 27 GENOMICS INSTRUMENTS, SYSTEMS, AND SOFTWARE MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 28 NORTH AMERICA: GENOMICS INSTRUMENTS, SYSTEMS, AND SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 29 EUROPE: GENOMICS INSTRUMENTS, SYSTEMS, AND SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 30 ASIA PACIFIC: GENOMICS INSTRUMENTS, SYSTEMS, AND SOFTWARE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

7 GENOMICS MARKET, BY TECHNOLOGY

  • 7.1 INTRODUCTION
    • TABLE 31 GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
  • 7.2 SEQUENCING
    • 7.2.1 LAUNCH OF NEW NGS PLATFORMS AND LOWER COST OF SEQUENCING TO DRIVE MARKET
    • TABLE 32 SEQUENCING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 33 NORTH AMERICA: SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 EUROPE: SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 35 ASIA PACIFIC: SEQUENCING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 PCR
    • 7.3.1 USE OF PCR TECHNOLOGIES FOR DRUG DISCOVERY TO PROPEL MARKET
    • TABLE 36 PCR MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 37 NORTH AMERICA: PCR MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 38 EUROPE: PCR MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 39 ASIA PACIFIC: PCR MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 FLOW CYTOMETRY
    • 7.4.1 APPLICATION OF FLOW CYTOMETRY IN AGRIGENOMICS TO SUPPORT MARKET GROWTH
    • TABLE 40 FLOW CYTOMETRY MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 41 NORTH AMERICA: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 EUROPE: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 43 ASIA PACIFIC: FLOW CYTOMETRY MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 MICROARRAYS
    • 7.5.1 HIGH ADOPTION OF NGS TO LIMIT GROWTH OF MICROARRAY TECHNOLOGIES
    • TABLE 44 MICROARRAYS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 45 NORTH AMERICA: MICROARRAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 46 EUROPE: MICROARRAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: MICROARRAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.6 OTHER TECHNOLOGIES
    • TABLE 48 OTHER TECHNOLOGIES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 49 NORTH AMERICA: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 50 EUROPE: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 51 ASIA PACIFIC: OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

8 GENOMICS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 52 GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 DRUG DISCOVERY AND DEVELOPMENT
    • 8.2.1 LARGEST APPLICATION SEGMENT OF GENOMICS MARKET
    • TABLE 53 GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 54 NORTH AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 55 EUROPE: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 56 ASIA PACIFIC: GENOMICS MARKET FOR DRUG DISCOVERY AND DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 DIAGNOSTICS
    • 8.3.1 GROWING APPLICATIONS OF GENOMICS IN DIAGNOSTICS FIELD TO PROPEL MARKET
    • TABLE 57 GRANTS, BY CANCER TYPE (AS OF JANUARY 2023)
    • TABLE 58 GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 59 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 60 EUROPE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 61 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 AGRICULTURE AND ANIMAL RESEARCH
    • 8.4.1 GENOMICS HELPS IMPROVE PRODUCTIVITY OF CROPS AND LIVESTOCK
    • TABLE 62 GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 63 NORTH AMERICA: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 64 EUROPE: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 65 ASIA PACIFIC: GENOMICS MARKET FOR AGRICULTURE AND ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 OTHER APPLICATIONS
    • TABLE 66 GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 67 NORTH AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 68 EUROPE: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 69 ASIA PACIFIC: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

9 GENOMICS MARKET, BY STUDY TYPE

  • 9.1 INTRODUCTION
    • TABLE 70 GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
  • 9.2 FUNCTIONAL GENOMICS
    • 9.2.1 INCREASED GENOMIC STUDIES TO POSITIVELY INFLUENCE MARKET GROWTH
    • TABLE 71 GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 72 NORTH AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 73 EUROPE: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 74 ASIA PACIFIC: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.3 BIOMARKER DISCOVERY
    • 9.3.1 RISE IN PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH
    • TABLE 75 GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 76 NORTH AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 77 EUROPE: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 78 ASIA PACIFIC: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.4 PATHWAY ANALYSIS
    • 9.4.1 DEVELOPMENT OF NEXT-GENERATION THERAPIES TO DRIVE MARKET
    • TABLE 79 GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 80 NORTH AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 81 EUROPE: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 82 ASIA PACIFIC: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.5 EPIGENOMICS
    • 9.5.1 INCREASE IN INVESTMENTS FOR EPIGENETICS RESEARCH TO SUPPORT MARKET GROWTH
    • TABLE 83 GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 84 NORTH AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 85 EUROPE: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 86 ASIA PACIFIC: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 9.6 OTHER STUDY TYPES
    • TABLE 87 GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 88 NORTH AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 89 EUROPE: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 90 ASIA PACIFIC: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2021-2028 (USD MILLION)

10 GENOMICS MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 91 GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.2 HOSPITALS AND CLINICS
    • 10.2.1 INCREASED APPLICATION IN DISEASE DIAGNOSIS AND TREATMENT TO DRIVE MARKET
    • TABLE 92 GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 93 NORTH AMERICA: GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 94 EUROPE: GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: GENOMICS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.3 ACADEMIC AND RESEARCH INSTITUTES
    • 10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USE OF GENOMICS PRODUCTS AMONG ACADEMIC AND RESEARCH INSTITUTES
    • TABLE 96 GENOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 97 NORTH AMERICA: GENOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 98 EUROPE: GENOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 99 ASIA PACIFIC: GENOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 10.4.1 GROWING IMPORTANCE OF BIOMARKERS FOR DRUG DISCOVERY TO DRIVE ADOPTION OF GENOMICS PRODUCTS AND SERVICES AMONG PHARMA AND BIOTECH COMPANIES
    • TABLE 100 GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 101 NORTH AMERICA: GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 102 EUROPE: GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 103 ASIA PACIFIC: GENOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 10.5 OTHER END USERS
    • TABLE 104 GENOMICS MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 105 NORTH AMERICA: GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 106 EUROPE: GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 107 ASIA PACIFIC: GENOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

11 GENOMICS MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 108 GENOMICS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 28 NORTH AMERICA: GENOMICS MARKET SNAPSHOT
    • TABLE 109 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 110 NORTH AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 111 NORTH AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 112 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 113 NORTH AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 114 NORTH AMERICA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.1 US
      • 11.2.1.1 US dominates North American genomics market
    • TABLE 115 US: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 116 US: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 117 US: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 118 US: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 US: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.2 CANADA
      • 11.2.2.1 Increasing research in genomics to drive market
    • TABLE 120 CANADA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 121 CANADA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 122 CANADA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 123 CANADA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 124 CANADA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.2.3 NORTH AMERICA: RECESSION IMPACT
  • 11.3 EUROPE
    • TABLE 125 EUROPE: GENOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 126 EUROPE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 127 EUROPE: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 128 EUROPE: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 129 EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 130 EUROPE: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.1 GERMANY
      • 11.3.1.1 Increasing awareness of NGS to boost market growth
    • TABLE 131 GERMANY: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 132 GERMANY: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 133 GERMANY: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 134 GERMANY: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 135 GERMANY: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.2 UK
      • 11.3.2.1 Availability of government funding and strategic collaborations with biotech firms to boost market growth
    • TABLE 136 UK: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 137 UK: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 138 UK: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 139 UK: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 140 UK: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.3 FRANCE
      • 11.3.3.1 Increasing government investments in genomics to drive market
    • TABLE 141 FRANCE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 142 FRANCE: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 143 FRANCE: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 144 FRANCE: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 145 FRANCE: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.4 ITALY
      • 11.3.4.1 Favorable funding scenario to drive adoption of sequencing technologies
    • TABLE 146 ITALY: GENOMICS, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 147 ITALY: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 148 ITALY: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 149 ITALY: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 150 ITALY: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.5 SPAIN
      • 11.3.5.1 Focus on expanding genomic research to support market growth
    • TABLE 151 SPAIN: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 152 SPAIN: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 153 SPAIN: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 154 SPAIN: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 155 SPAIN: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.6 REST OF EUROPE
    • TABLE 156 REST OF EUROPE: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 157 REST OF EUROPE: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 158 REST OF EUROPE: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 159 REST OF EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 REST OF EUROPE: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.3.7 EUROPE: RECESSION IMPACT
  • 11.4 ASIA PACIFIC
    • FIGURE 29 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT
    • TABLE 161 ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 162 ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 163 ASIA PACIFIC: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 164 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 165 ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 166 ASIA PACIFIC: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.1 CHINA
      • 11.4.1.1 Fastest-growing market in Asia Pacific
    • TABLE 167 CHINA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 168 CHINA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 169 CHINA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 170 CHINA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 171 CHINA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.2 JAPAN
      • 11.4.2.1 Growing NGS market to support market growth
    • TABLE 172 JAPAN: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 173 JAPAN: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 174 JAPAN: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 175 JAPAN: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 176 JAPAN: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.3 INDIA
      • 11.4.3.1 Emergence of local players and increasing adoption of genomics technologies to aid market growth
    • TABLE 177 INDIA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 178 INDIA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 179 INDIA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 180 INDIA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 181 INDIA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.4 AUSTRALIA
      • 11.4.4.1 Increase in precision medicine and academic studies to propel market growth
    • TABLE 182 AUSTRALIA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 183 AUSTRALIA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 184 AUSTRALIA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 185 AUSTRALIA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 186 AUSTRALIA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.5 SOUTH KOREA
      • 11.4.5.1 Government initiatives to favor market growth
    • TABLE 187 SOUTH KOREA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 188 SOUTH KOREA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 189 SOUTH KOREA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 190 SOUTH KOREA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 191 SOUTH KOREA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.6 REST OF ASIA PACIFIC
    • TABLE 192 REST OF ASIA PACIFIC: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 193 REST OF ASIA PACIFIC: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 194 REST OF ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 195 REST OF ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 196 REST OF ASIA PACIFIC: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.4.7 ASIA PACIFIC: RECESSION IMPACT
  • 11.5 LATIN AMERICA
    • 11.5.1 EXPANSION OF KEY PLAYERS TO BOOST MARKET GROWTH
    • TABLE 197 LATIN AMERICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 198 LATIN AMERICA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 199 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 200 LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 201 LATIN AMERICA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.5.2 LATIN AMERICA: RECESSION IMPACT
  • 11.6 MIDDLE EAST AND AFRICA
    • 11.6.1 INCREASING ADOPTION OF GENETIC TESTING AND RISING HIV & CANCER INCIDENCE TO DRIVE MARKET
    • TABLE 202 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY PRODUCT & SERVICE, 2021-2028 (USD MILLION)
    • TABLE 203 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
    • TABLE 204 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 205 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY STUDY TYPE, 2021-2028 (USD MILLION)
    • TABLE 206 MIDDLE EAST AND AFRICA: GENOMICS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 11.6.2 MIDDLE EAST AND AFRICA: RECESSION IMPACT

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • FIGURE 30 GENOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
  • 12.3 REVENUE ANALYSIS
    • FIGURE 31 REVENUE ANALYSIS OF KEY COMPANIES, 2020-2022
  • 12.4 MARKET SHARE ANALYSIS
    • FIGURE 32 GENOMICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022
    • TABLE 207 GENOMICS MARKET: DEGREE OF COMPETITION
  • 12.5 COMPANY EVALUATION MATRIX
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • FIGURE 33 GENOMICS MARKET: COMPANY EVALUATION MATRIX, 2022
  • 12.6 COMPETITIVE BENCHMARKING
    • 12.6.1 OVERALL COMPANY FOOTPRINT (32 COMPANIES)
    • TABLE 208 PRODUCT & SERVICE AND REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 12.6.2 PRODUCT & SERVICE FOOTPRINT OF COMPANIES (32 COMPANIES)
    • TABLE 209 PRODUCT & SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 12.6.3 REGIONAL FOOTPRINT OF COMPANIES (32 COMPANIES)
    • TABLE 210 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
  • 12.7 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES
    • 12.7.1 PROGRESSIVE COMPANIES
    • 12.7.2 STARTING BLOCKS
    • 12.7.3 RESPONSIVE COMPANIES
    • 12.7.4 DYNAMIC COMPANIES
    • FIGURE 34 GENOMICS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022
  • 12.8 COMPETITIVE BENCHMARKING OF STARTUPS/SMES
    • TABLE 211 GENOMICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • 12.9 COMPETITIVE SCENARIO AND TRENDS
    • 12.9.1 PRODUCT/SERVICE LAUNCHES
    • TABLE 212 GENOMICS MARKET: KEY PRODUCT/SERVICE LAUNCHES, JANUARY 2020-APRIL 2023
    • 12.9.2 DEALS
    • TABLE 213 GENOMICS MARKET: KEY DEALS, JANUARY 2020-APRIL 2023
    • 12.9.3 OTHER DEVELOPMENTS
    • TABLE 214 GENOMICS MARKET: OTHER KEY DEVELOPMENTS, JANUARY 2020-APRIL 2023

13 COMPANY PROFILES

  • 13.1 MAJOR PLAYERS
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 13.1.1 ILLUMINA, INC.
    • TABLE 215 ILLUMINA, INC.: BUSINESS OVERVIEW
    • FIGURE 35 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
    • 13.1.2 THERMO FISHER SCIENTIFIC INC.
    • TABLE 216 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 36 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
    • 13.1.3 F. HOFFMANN-LA ROCHE LTD.
    • TABLE 217 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
    • FIGURE 37 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
    • 13.1.4 DANAHER CORPORATION
    • TABLE 218 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
    • 13.1.5 QIAGEN N.V.
    • TABLE 219 QIAGEN N.V.: BUSINESS OVERVIEW
    • FIGURE 39 QIAGEN N.V.: COMPANY SNAPSHOT (2022)
    • 13.1.6 AGILENT TECHNOLOGIES, INC.
    • TABLE 220 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
    • FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
    • 13.1.7 PERKINELMER INC.
    • TABLE 221 PERKINELMER INC.: BUSINESS OVERVIEW
    • FIGURE 41 PERKINELMER INC.: COMPANY SNAPSHOT (2022)
    • 13.1.8 BIO-RAD LABORATORIES, INC.
    • TABLE 222 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 42 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
    • 13.1.9 EUROFINS SCIENTIFIC
    • TABLE 223 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
    • FIGURE 43 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2022)
    • 13.1.10 PACIFIC BIOSCIENCES
    • TABLE 224 PACIFIC BIOSCIENCES: BUSINESS OVERVIEW
    • FIGURE 44 PACIFIC BIOSCIENCES: COMPANY SNAPSHOT (2022)
    • 13.1.11 OXFORD NANOPORE TECHNOLOGIES PLC
    • TABLE 225 OXFORD NANOPORE TECHNOLOGIES PLC: BUSINESS OVERVIEW
    • FIGURE 45 OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2022)
    • 13.1.12 TAKARA BIO INC.
    • TABLE 226 TAKARA BIO INC.: BUSINESS OVERVIEW
    • FIGURE 46 TAKARA BIO INC.: COMPANY SNAPSHOT (2022)
    • 13.1.13 BGI GROUP
    • TABLE 227 BGI GROUP: BUSINESS OVERVIEW
    • 13.1.14 EPPENDORF AG
    • TABLE 228 EPPENDORF AG: BUSINESS OVERVIEW
    • FIGURE 47 EPPENDORF AG: COMPANY SNAPSHOT (2021)
    • 13.1.15 MERCK KGAA
    • TABLE 229 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 48 MERCK KGAA: COMPANY SNAPSHOT (2022)
    • 13.1.16 BECTON, DICKINSON AND COMPANY
    • TABLE 230 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 49 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
    • 13.1.17 ABBOTT LABORATORIES
    • TABLE 231 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 50 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
    • 13.1.18 23ANDME, INC.
    • TABLE 232 23ANDME, INC.: BUSINESS OVERVIEW
    • FIGURE 51 23ANDME, INC.: COMPANY SNAPSHOT (2021)
    • 13.1.19 10X GENOMICS
    • TABLE 233 10X GENOMICS: BUSINESS OVERVIEW
    • FIGURE 52 10X GENOMICS: COMPANY SNAPSHOT (2022)
    • 13.1.20 NEW ENGLAND BIOLABS
    • TABLE 234 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
    • 13.1.21 PROMEGA CORPORATION
    • TABLE 235 PROMEGA CORPORATION: BUSINESS OVERVIEW
    • 13.1.22 CREATIVE BIOGENE
    • TABLE 236 CREATIVE BIOGENE: BUSINESS OVERVIEW
    • 13.1.23 NOVOGENE CO., LTD.
    • TABLE 237 NOVOGENE CO., LTD.: BUSINESS OVERVIEW
    • 13.1.24 ULTIMA GENOMICS, INC.
    • TABLE 238 ULTIMA GENOMICS, INC. BUSINESS OVERVIEW
    • 13.1.25 FREENOME HOLDINGS, INC.
    • TABLE 239 FREENOME HOLDINGS, INC.: BUSINESS OVERVIEW
  • 13.2 OTHER PLAYERS
    • 13.2.1 QUEST DIAGNOSTICS
    • 13.2.2 MYRIAD GENETICS, INC.
    • 13.2.3 PERSONALIS, INC.
    • 13.2.4 HELIX OPCO, LLC
    • 13.2.5 POLARIS GENOMICS
    • 13.2.6 PHALANX BIOTECH GROUP
    • 13.2.7 GENOMIQA PTY LTD
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 DISCUSSION GUIDE
  • 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3 CUSTOMIZATION OPTIONS
  • 14.4 RELATED REPORTS
  • 14.5 AUTHOR DETAILS